IL38441A - Glycoside-hydrolase inhibitors of microbial origin,their production and their use - Google Patents

Glycoside-hydrolase inhibitors of microbial origin,their production and their use

Info

Publication number
IL38441A
IL38441A IL7138441A IL3844171A IL38441A IL 38441 A IL38441 A IL 38441A IL 7138441 A IL7138441 A IL 7138441A IL 3844171 A IL3844171 A IL 3844171A IL 38441 A IL38441 A IL 38441A
Authority
IL
Israel
Prior art keywords
glycoside
production
microbial origin
hydrolase inhibitors
hydrolase
Prior art date
Application number
IL7138441A
Other languages
English (en)
Other versions
IL38441A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL38441A0 publication Critical patent/IL38441A0/xx
Publication of IL38441A publication Critical patent/IL38441A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/896—Streptomyces fradiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/907—Streptosporangium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
IL7138441A 1970-12-28 1971-12-24 Glycoside-hydrolase inhibitors of microbial origin,their production and their use IL38441A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2064092A DE2064092C2 (de) 1970-12-28 1970-12-28 Inhibitoren für Glykosidhydrolasen aus Actinomyceten

Publications (2)

Publication Number Publication Date
IL38441A0 IL38441A0 (en) 1972-02-29
IL38441A true IL38441A (en) 1974-10-22

Family

ID=5792372

Family Applications (1)

Application Number Title Priority Date Filing Date
IL7138441A IL38441A (en) 1970-12-28 1971-12-24 Glycoside-hydrolase inhibitors of microbial origin,their production and their use

Country Status (28)

Country Link
US (1) US3876766A (da)
JP (3) JPS5734996B1 (da)
KR (1) KR780000248B1 (da)
AR (1) AR193370A1 (da)
AT (1) AT330122B (da)
AU (1) AU461521B2 (da)
BE (1) BE777387A (da)
BG (3) BG25654A3 (da)
CA (1) CA979833A (da)
CH (1) CH594051A5 (da)
CS (1) CS167961B2 (da)
DD (1) DD99395A5 (da)
DE (1) DE2064092C2 (da)
DK (1) DK139533C (da)
ES (1) ES398358A1 (da)
FI (1) FI49774C (da)
FR (1) FR2120073B1 (da)
GB (1) GB1374751A (da)
IE (1) IE35920B1 (da)
IL (1) IL38441A (da)
LU (1) LU64319A1 (da)
NL (1) NL175199C (da)
NO (1) NO135873C (da)
PL (1) PL82900B1 (da)
RO (3) RO63065A (da)
SE (1) SE398357B (da)
SU (1) SU454750A3 (da)
ZA (1) ZA718677B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2209834C3 (de) * 1972-03-01 1978-04-20 Bayer Ag, 5090 Leverkusen Herstellung von Saccharase-Inhibitoren
DE2209832C3 (de) * 1972-03-01 1979-03-29 Bayer Ag, 5090 Leverkusen Herstellung von Saccharaseinhibitoren
DE2209833C3 (de) * 1972-03-01 1978-06-01 Bayer Ag, 5090 Leverkusen Herstellung eines Amylaseinhibitors
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4010258A (en) * 1974-03-15 1977-03-01 Ajinomoto Co., Inc. Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
FR2338707A1 (fr) * 1976-01-22 1977-08-19 Rhone Poulenc Ind Nouvel inhibiteur de glyco-hydrolases et sa preparation par culture d'un streptomyces
DE2658563A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Inhibitoren fuer glykosid-hydrolasen aus bacillen
DE2701890C2 (de) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Peptielischer Glycosidhydrolase-Inhibitor aus einem Streptomyceten und seine Verwendung
DE2719912C3 (de) * 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
GB2016497A (en) * 1978-02-10 1979-09-26 Taisho Pharmaceutical Co Ltd Microbiological production of amylase inhibitor
CA1121290A (en) * 1978-02-14 1982-04-06 Yasuji Suhara Amino sugar derivatives
JPS62160696A (ja) * 1986-01-07 1987-07-16 シャープ株式会社 電子式自動点滅器
EP0257418B1 (de) * 1986-08-13 1993-05-19 Hoechst Aktiengesellschaft Oxiran-Pseudooligosaccharide, Verfahren zu deren Herstellung, deren Verwendung und pharmazeutische Präparate
US5464828A (en) * 1988-03-02 1995-11-07 Chugai Pharmaceutical Co., Ltd. Aqueous suspension of sucralfate
DE19507214A1 (de) * 1995-03-02 1996-10-31 Bayer Ag Acarbose-Biosynthesegene aus Actinoplanes sp., Verfahren zu ihrer Isolierung sowie ihre Verwendung
EP0796915A3 (de) * 1996-03-22 1999-04-14 Bayer Ag Verfahren zur Herstellung sowie zur Verwendung von Acarviosyl-Transferase bei der Umwandlung von Acarbose-Homologen in Acarbose, zur Herstellung von Acarbose-Homologen
DE19637591A1 (de) * 1996-09-13 1998-03-19 Bayer Ag Osmokontrolliertes Fermentationsverfahren zur Herstellung von Acarbose
WO2001030796A1 (en) 1999-10-28 2001-05-03 Chong Kun Dang Pharmaceutical Corp. A process for preparing acarbose with high purity
HRP20010792A2 (en) 2001-10-26 2003-04-30 Pliva D D Acarbose purification process
CN104144942A (zh) 2011-12-08 2014-11-12 拜耳知识产权有限责任公司 来自游动放线菌属菌种se50/110的新的放射菌整合和接合元件作为用于相关放线菌基因转化的质粒
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
JP2022553183A (ja) 2019-10-16 2022-12-22 バイエル・アクチエンゲゼルシヤフト アカルボースの改善された形成方法
US11802838B2 (en) 2020-03-23 2023-10-31 Bay State Milling Company Rapid high amylose wheat seed purity test

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127315A (en) * 1964-03-31 Hypocholesterolemic agent m-

Also Published As

Publication number Publication date
DE2064092A1 (de) 1972-07-20
FI49774C (fi) 1975-10-10
BE777387A (fr) 1972-06-28
CA979833A (en) 1975-12-16
CS167961B2 (da) 1976-05-28
CH594051A5 (da) 1977-12-30
JPS6234396B2 (da) 1987-07-27
DK139533B (da) 1979-03-05
PL82900B1 (da) 1975-10-31
RO61400A (da) 1977-01-15
NO135873C (da) 1977-06-15
IE35920L (en) 1972-06-28
IE35920B1 (en) 1976-06-23
FI49774B (da) 1975-06-30
SU454750A3 (ru) 1974-12-25
FR2120073A1 (da) 1972-08-11
GB1374751A (en) 1974-11-20
DK139533C (da) 1979-08-20
IL38441A0 (en) 1972-02-29
NO135873B (da) 1977-03-07
NL175199B (nl) 1984-05-01
AU3721471A (en) 1973-09-27
JPS57150395A (en) 1982-09-17
LU64319A1 (da) 1972-06-13
BG26002A4 (bg) 1979-01-12
AU461521B2 (en) 1975-05-29
ZA718677B (en) 1972-09-27
NL175199C (nl) 1984-10-01
JPS6216638B2 (da) 1987-04-14
JPS5734996B1 (da) 1982-07-26
SE398357B (sv) 1977-12-19
DE2064092C2 (de) 1983-06-01
ES398358A1 (es) 1974-09-01
RO63065A (fr) 1979-02-15
AT330122B (de) 1976-06-10
BG26003A4 (bg) 1979-01-12
DD99395A5 (da) 1973-08-05
BG25654A3 (bg) 1978-11-10
ATA1111571A (de) 1975-09-15
JPS57150396A (en) 1982-09-17
AR193370A1 (es) 1973-04-23
FR2120073B1 (da) 1975-12-26
NL7117893A (da) 1972-06-30
RO63064A (fr) 1978-06-15
KR780000248B1 (en) 1978-07-06
US3876766A (en) 1975-04-08

Similar Documents

Publication Publication Date Title
IL38441A (en) Glycoside-hydrolase inhibitors of microbial origin,their production and their use
ZA713624B (en) Polyetheramines,their production and use
EG10637A (en) New aminophenylamidines,their production and their pharmaceutical use
IL37025A (en) Aminophenylamidines,their production and their medical use
CA994340A (en) N-substituted imidazoles, their production and use
IL35986A0 (en) Amylase inhibitor,its production and use
AU462715B2 (en) Sulphonyk-2-(arylhydrazino)-2-imidazolines processes for their manufacture and their use as ectroparasiticides
AU455271B2 (en) Acylated arylhydrazino-2 imidazolines, processes for their manufacture and their use as ectiparasiticides
ZA712484B (en) Enzyme inhibitors
CA932337A (en) 2-aryliminopyrrolidines and their production
IL36106A0 (en) Phosphonopropionic acid amide derivatives,their manufacture and their use
CA852745A (en) .alpha. AND .gamma.-PICOLINE PRODUCTION
CA967152A (en) 1-polyfluoralkyl-benzodiazepines and methods for their production
JPS55143947A (en) Manufacture of enzyme inhibitor
ZA71641B (en) New azo compounds,their production and use
AU461419B2 (en) Herbicidally-active substituted phenylthiocarbamates and their manufacture and use
CA969944A (en) Hydrazonium salt, production of the same and composition thereof
CA929943A (en) Substituted aminodihalopyridines and method of use
CA843308A (en) Tractants and method of use
AU456942B2 (en) Azo compounds of low solubility, their production and use
CA851263A (en) Poly-n-oxides and their production
CA985678A (en) Benzomorphanes and their production
CA848448A (en) Ortho-substitued 2-phenyl-imino-1-aza-cycloalkanes and their production
CA845269A (en) Polyvinylpyridine-n-oxides and their production
CA854307A (en) Poly-n-oxides and their production